• TRIM66 and Monogenic Olfactory Receptor Expression

  2026-08-24

  The reference study identifies TRIM66 as an epigenetic repressor that helps convert initially polygenic olfactory receptor transcription into stable monogenic expression in mature olfactory sensory neurons. Its loss disrupts receptor selection, neural olfactory processing, and innate odor-guided behavior, providing a mechanistic link between enhancer repression and sensory function.

• Lypressin Acetate: A Receptor-to-Assay Guide

  2026-08-23

  Lypressin acetate is a lysine-substituted vasopressin analog with a distinctive three-receptor pharmacology. This guide explains how to translate its antidiuretic, vasopressor, and emerging antiviral evidence into better assay design and interpretation.

• Cholecystokinin Octapeptide Ammonium Workflows

  2026-08-22

  Cholecystokinin octapeptide ammonium enables controlled CCK1R and CCK2R stimulation across neuronal, immune, cardiac, and zebrafish behavior assays. This practical guide translates sulfated peptide biology into formulation, dosing, receptor-validation, and troubleshooting workflows while preserving the critical distinction between published evidence and experimental recommendations.

• Atrial Natriuretic Peptide: Applied Lab Workflows

  2026-08-22

  Build reproducible vascular, renal, and adipose assays with rat Atrial Natriuretic Peptide while controlling peptide handling, dose selection, and phenotype validation. A reference study on adiponectin offers a useful causal-design framework, but its APN abbreviation and neuroinflammatory model must not be confused with ANP peptide experiments.

• RWJ 67657: p38α/β Assay Workflow

  2026-08-21

  RWJ 67657, also known as JNJ-3026582, combines selective p38α/β pathway interrogation with practical cytokine and phospho-protein readouts. This workflow shows how to connect biochemical potency, TNF-alpha responses, and p38α dephosphorylation without treating mechanistic hypotheses as established clinical evidence.

• 2,5-di-tert-butylbenzene-1,4-diol (BHQ)

  2026-08-20

  A scenario-based guide to using 2,5-di-tert-butylbenzene-1,4-diol (BHQ), SKU B6648, in calcium signaling, viability, proliferation, and cytotoxicity workflows. It covers solvent compatibility, controls, interpretation limits, protocol design, and practical supplier-selection criteria.

• VE-821: From ATR Biology to Translational Strategy

  2026-08-20

  VE-821 offers a selective way to interrogate ATR–Chk1 checkpoint signaling, replication stress, radiosensitization, and combination therapy. This thought-leadership perspective connects established oncology applications with emerging epigenetic insights from human bocavirus research while clearly separating evidence from hypothesis.

• Hydroxychloroquine Sulfate Protocol Guide

  2026-08-19

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible way to study autophagy pathway modulation and TLR7/9 signaling in autoimmune disease research. It is suited to short-term, water-based cell and animal workflows, but should not be selected when DMSO or ethanol solubility or long-term solution storage is required.

• DRD2 Variants and Pathogenic G-Protein Signaling

  2026-08-19

  A 2024 Biochemical Pharmacology study compared two pathogenic DRD2 variants associated with hyperkinetic movement disorders and identified enhanced constitutive and agonist-induced G-protein signaling as a likely explanation for their different clinical severity. Its combination of cellular pharmacology, arrestin and G-protein assays, cAMP measurements, thermal inactivation, and molecular dynamics provides a useful framework for interpreting disease-linked GPCR mutations.

• Pazopanib Hydrochloride: Assay Workflows

  2026-08-18

  Build more informative Pazopanib Hydrochloride response assays by separating growth inhibition from actual cell killing. This workflow combines target-informed dosing, time-resolved measurements, and troubleshooting guidance for renal cell carcinoma research, soft tissue sarcoma studies, and broader cancer research.

• Alternariol and LX-2 Fibrotic Reprogramming

  2026-08-18

  The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can drive LX-2 hepatic stellate cells toward a contractile, myofibroblast-like phenotype, whereas tenuazonic acid produces no comparable response. By combining lncRNA-mRNA omics with pathway-focused validation, the work connects Alternaria toxin exposure with NF-κB signaling, ferroptosis, autophagy, and a proposed CotA laccase detoxification strategy.

• Br-DAPI for DNA Quantification and Cell Imaging

  2026-08-17

  Br-DAPI combines selective A/T-rich DNA binding with approximately 20-fold fluorescence enhancement for sensitive nuclear imaging and DNA measurement. Its membrane permeability supports both live-cell DNA staining and fixed-cell workflows, including cardiometabolic models of lipotoxicity and endoplasmic reticulum stress.

• Necrostatin 2: Reading Cell Death at the Membrane

  2026-08-17

  Necrostatin 2 (Nec-2) enables pathway-focused necroptosis inhibition while helping researchers distinguish kinase-dependent signaling from terminal plasma-membrane failure. This guide integrates product handling, assay design, ischemic stroke research, and insights from recent ferroptosis biology.

• Temafloxacin Activity Against Gram-Negative Bacteria

  2026-08-16

  This 1991 overview compared the in vitro activity of temafloxacin with ciprofloxacin and ofloxacin across respiratory, enteric, sexually transmitted, and other gram-negative pathogens. Its central contribution was to show broad and often high potency against many gram-negative organisms while identifying a meaningful limitation against Pseudomonas aeruginosa.

• Prevotella copri, IPA, and Breast Cancer Progression

  2026-08-15

  A 2024 Gut Microbes study identifies Prevotella copri as a microbiota-associated factor that can accelerate breast cancer growth by consuming host tryptophan and reducing intrinsic indole-3-pyruvic acid. The work connects this metabolic depletion to UHRF1 regulation and impaired AMPK signaling, providing a mechanistic framework for studying gut microbial control of tumor metabolism.

7864 records 1/525 page Next 12345 下5页 Last page